These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18784222)

  • 1. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults?
    Hamel MJ; Greene C; Chiller T; Ouma P; Polyak C; Otieno K; Williamson J; Shi YP; Feikin DR; Marston B; Brooks JT; Poe A; Zhou Z; Ochieng B; Mintz E; Slutsker L
    Am J Trop Med Hyg; 2008 Sep; 79(3):320-30. PubMed ID: 18784222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation.
    Hamel MJ; Poe A; Bloland P; McCollum A; Zhou Z; Shi YP; Ouma P; Otieno K; Vulule J; Escalante A; Udhayakumar V; Slutsker L
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):338-45. PubMed ID: 18321547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members.
    Malamba SS; Mermin J; Reingold A; Lule JR; Downing R; Ransom R; Kigozi A; Hunt BM; Hubbard A; Rosenthal PJ; Dorsey G
    Am J Trop Med Hyg; 2006 Sep; 75(3):375-80. PubMed ID: 16968909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily trimethoprim-sulfamethoxazole prophylaxis rapidly induces corresponding resistance among intestinal Escherichia coli of HIV-infected adults in Kenya.
    Chiller TM; Polyak CS; Brooks JT; Williamson J; Ochieng B; Shi YP; Ouma P; Greene C; Hamel M; Vulule J; Bopp C; Slutsker L; Mintz E
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):165-9. PubMed ID: 19357424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi.
    Patnaik P; Jere CS; Miller WC; Hoffman IF; Wirima J; Pendame R; Meshnick SR; Taylor TE; Molyneux ME; Kublin JG
    J Infect Dis; 2005 Sep; 192(6):984-91. PubMed ID: 16107950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea.
    Campbell JD; Moore D; Degerman R; Kaharuza F; Were W; Muramuzi E; Odongo G; Wetaka M; Mermin J; Tappero JW
    Clin Infect Dis; 2012 Apr; 54(8):1204-11. PubMed ID: 22423133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi.
    Zachariah R; Spielmann MP; Harries AD; Gomani P; Bakali E
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1046-50. PubMed ID: 12546111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV.
    Guiguet M; Furco A; Tattevin P; Costagliola D; Molina JM;
    HIV Med; 2007 Mar; 8(2):124-30. PubMed ID: 17352769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of home-based water chlorination and safe storage on diarrhea among persons with human immunodeficiency virus in Uganda.
    Lule JR; Mermin J; Ekwaru JP; Malamba S; Downing R; Ransom R; Nakanjako D; Wafula W; Hughes P; Bunnell R; Kaharuza F; Coutinho A; Kigozi A; Quick R
    Am J Trop Med Hyg; 2005 Nov; 73(5):926-33. PubMed ID: 16282305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.
    Shah SN; Smith EE; Obonyo CO; Kain KC; Bloland PB; Slutsker L; Hamel MJ
    J Infect Dis; 2006 Dec; 194(11):1519-28. PubMed ID: 17083036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.
    Mermin J; Lule J; Ekwaru JP; Malamba S; Downing R; Ransom R; Kaharuza F; Culver D; Kizito F; Bunnell R; Kigozi A; Nakanjako D; Wafula W; Quick R
    Lancet; 2004 Oct 16-22; 364(9443):1428-34. PubMed ID: 15488218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.
    Mwaungulu FB; Floyd S; Crampin AC; Kasimba S; Malema S; Kanyongoloka H; Harries AD; Glynn JR; Fine PE
    Bull World Health Organ; 2004 May; 82(5):354-63. PubMed ID: 15298226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiologies and manifestations of persistent diarrhea in adults with HIV-1 infection: a case-control study in Lima, Peru.
    Cárcamo C; Hooton T; Wener MH; Weiss NS; Gilman R; Arevalo J; Carrasco J; Seas C; Caballero M; Holmes KK
    J Infect Dis; 2005 Jan; 191(1):11-9. PubMed ID: 15592997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance with cotrimoxazole prophylaxis for the prevention of opportunistic infections in HIV-positive tuberculosis patients in Thyolo district, Malawi.
    Zachariah R; Harries AD; Arendt V; Wennig R; Schneider S; Spielmann M; Panarotto E; Gomani P; Salaniponi FM
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):843-6. PubMed ID: 11573896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cotrimoxazole prophylaxis for HIV-positive TB patients in developing countries.
    Zachariah R; Massaquoi M
    Trop Doct; 2006 Apr; 36(2):79-82. PubMed ID: 16611438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
    Ribera E; Fernandez-Sola A; Juste C; Rovira A; Romero FJ; Armadans-Gil L; Ruiz I; Ocaña I; Pahissa A
    Clin Infect Dis; 1999 Dec; 29(6):1461-6. PubMed ID: 10585796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balancing individual benefit against public health risk: the impact of cotrimoxazole prophylaxis in HIV-infected patients on antimicrobial resistance.
    Hamer DH; Gill CJ
    Am J Trop Med Hyg; 2008 Sep; 79(3):299-300. PubMed ID: 18784218
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary infections due to multi-drug-resistant Escherichia coli among persons with HIV disease at a tertiary AIDS care centre in South India.
    Vignesh R; Shankar EM; Murugavel KG; Kumarasamy N; Sekar R; Irene P; Solomon S; Balakrishnan P
    Nephron Clin Pract; 2008; 110(1):c55-7. PubMed ID: 18724067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and determinants of Pseudomonas aeruginosa infection among persons with HIV: association with hospital exposure.
    Sorvillo F; Beall G; Turner PA; Beer VL; Kovacs AA; Kerndt PR
    Am J Infect Control; 2001 Apr; 29(2):79-84. PubMed ID: 11287873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection.
    Gill CJ; Sabin LL; Tham J; Hamer DH
    Bull World Health Organ; 2004 Apr; 82(4):290-7. PubMed ID: 15259258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.